Page last updated: 2024-11-02

pioglitazone and Atrioventricular Nodal Re-Entrant Tachycardia

pioglitazone has been researched along with Atrioventricular Nodal Re-Entrant Tachycardia in 1 studies

Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Morrow, JP1
Katchman, A1
Son, NH1
Trent, CM1
Khan, R1
Shiomi, T1
Huang, H1
Amin, V1
Lader, JM1
Vasquez, C1
Morley, GE1
D'Armiento, J1
Homma, S1
Goldberg, IJ1
Marx, SO1

Other Studies

1 other study available for pioglitazone and Atrioventricular Nodal Re-Entrant Tachycardia

ArticleYear
Mice with cardiac overexpression of peroxisome proliferator-activated receptor γ have impaired repolarization and spontaneous fatal ventricular arrhythmias.
    Circulation, 2011, Dec-20, Volume: 124, Issue:25

    Topics: Action Potentials; Animals; Calcium; Connexin 43; Death, Sudden, Cardiac; Disease Models, Animal; El

2011